| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.22B | 16.20B | 13.60B | 12.59B | 12.08B | 11.38B |
| Gross Profit | 2.76B | 2.50B | 1.87B | 1.72B | 1.66B | 1.53B |
| EBITDA | 1.20B | 982.00M | 555.36M | 469.71M | 456.51M | 465.07M |
| Net Income | 565.00M | 423.00M | 251.95M | 167.08M | 143.43M | 124.09M |
Balance Sheet | ||||||
| Total Assets | 21.43B | 20.84B | 16.80B | 15.03B | 16.41B | 14.36B |
| Cash, Cash Equivalents and Short-Term Investments | 612.00M | 932.00M | 954.88M | 1.13B | 921.91M | 850.90M |
| Total Debt | 10.34B | 8.99B | 6.26B | 4.09B | 4.97B | 6.31B |
| Total Liabilities | 15.86B | 15.45B | 11.90B | 10.67B | 12.24B | 10.50B |
| Stockholders Equity | 5.56B | 5.38B | 4.90B | 4.37B | 4.16B | 3.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.75B | -2.27B | 1.08B | 1.45B | -32.85M |
| Operating Cash Flow | 0.00 | -2.17B | -1.90B | 1.29B | 1.89B | 198.15M |
| Investing Cash Flow | 0.00 | -585.77M | -370.50M | -158.97M | -440.26M | -182.32M |
| Financing Cash Flow | 0.00 | 2.73B | 2.09B | -920.58M | -1.38B | -102.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.34B | 6.57 | ― | 3.41% | -3.27% | 572.42% | |
70 Outperform | ¥18.29B | 34.60 | ― | 0.68% | 27.58% | -19.61% | |
65 Neutral | ¥23.63B | 49.90 | ― | 1.73% | 26.09% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥32.01B | 20.12 | ― | 3.56% | -3.85% | -45.64% | |
57 Neutral | ¥14.36B | -29.07 | ― | 5.43% | 1.46% | 89.88% | |
46 Neutral | ¥17.57B | -11.54 | ― | 4.21% | 2.79% | -281.15% |